{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:08:37Z","timestamp":1768770517838,"version":"3.49.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Cell surface proteolytic processing of anthrax protective antigen by furin or other furin-related proteases is required for its oligomerization, endocytosis, and function as a translocon for anthrax lethal and edema factors. Countering toxin lethality is essential to developing effective chemotherapies for anthrax infections that have proceeded beyond the stage at which antibiotics are effective. The primary target for toxin is the macrophage, which can be killed by lethal factor via both necrotic and apoptotic pathways. Here we show that three high-affinity inhibitors of furin efficiently blocked killing of murine J774A.1 macrophages by recombinant protective antigen plus lethal factor: RRD-eglin and RRDG-eglin, developed by engineering the protein protease inhibitor eglin c, and the peptide boronic acid inhibitor acetyl-Arg-Glu-Lys-boroArg pinanediol. Inhibition of killing was dose dependent and correlated with prevention of protective antigen processing. Previous studies have shown that weak bases, such as chloroquine, which neutralize acidic compartments, also interfere with toxin-dependent killing. Here we show that combining furin inhibitors and chloroquine strongly augments the inhibition of toxin-dependent killing, suggesting that combined use of antifurin drugs and chloroquine might provide enhanced therapeutic benefits. Reversible furin inhibitors protected against anthrax toxin killing for at least 5 h, but by 8 h, toxin-dependent killing resumed even though furin inhibitors were still active. An irreversible chloromethylketone inhibitor did not exhibit this loss of protection.<\/jats:p>","DOI":"10.1128\/aac.49.9.3875-3882.2005","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T22:07:52Z","timestamp":1125094072000},"page":"3875-3882","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["Protection from Anthrax Toxin-Mediated Killing of Macrophages by the Combined Effects of Furin Inhibitors and Chloroquine"],"prefix":"10.1128","volume":"49","author":[{"given":"Tomoko","family":"Komiyama","sequence":"first","affiliation":[{"name":"Departments of Biological Chemistry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel A.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Departments of Biological Chemistry"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200211018"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/jm00020a016","volume":"38","year":"1995","unstructured":"Angliker, H. 1995. Synthesis of tight binding inhibitors and their action on the proprotein-processing enzyme furin. J. Med. Chem.38:4014-4018.","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bj2930075","volume":"293","year":"1993","unstructured":"Angliker, H., P. Wikstrom, E. Shaw, C. Brenner, and R. S. Fuller. 1993. The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. Biochem. J.293:75-81.","journal-title":"Biochem. J."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/424853"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2000.00052.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/n35101999"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47322-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(01)02294-6"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411107"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00034983.2000.11813579","volume":"94","year":"2000","unstructured":"Dua, V. K., N. C. Gupta, P. K. Kar, J. Nand, G. Edwards, V. P. Sharma, and S. K. Subbarao. 2000. Chloroquine and desethylchloroquine concentrations in blood cells and plasma from Indian patients infected with sensitive or resistant Plasmodium falciparum. Ann. Trop. Med. Parasitol.94:565-570.","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5364.734"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jps.2600760714","volume":"76","year":"1987","unstructured":"Ferrari, V., and D. J. Cutler. 1987. Temperature dependence of the acid dissociation constants of chloroquine. J. Pharm. Sci.76:554-556.","journal-title":"J. Pharm. Sci."},{"key":"e_1_3_2_14_2","unstructured":"Fersht A. R. 1985. Enzyme structure and mechanism p. 106-107. W. H. Freeman and Co. New York N.Y."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)38364-3"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.1.245-252.1993"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.1.82-87.1995"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.5.1066-1069.1988"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0022-2836(89)90336-7","volume":"210","year":"1989","unstructured":"Gros, P., C. Betzel, Z. Dauter, K. S. Wilson, and W. G. Hol. 1989. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content. J. Mol. Biol.210:347-367.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1021\/bi035849h","volume":"43","year":"2004","unstructured":"Holyoak, T., C. A. Kettner, G. A. Petsko, R. S. Fuller, and D. Ringe. 2004. Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases. Biochemistry43:2412-2421.","journal-title":"Biochemistry"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/bi034434t","volume":"42","year":"2003","unstructured":"Holyoak, T., M. A. Wilson, T. D. Fenn, C. A. Kettner, G. A. Petsko, R. S. Fuller, and D. Ringe. 2003. 2.4 A resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor. Biochemistry42:6709-6718.","journal-title":"Biochemistry"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1021\/jo015753y","volume":"66","year":"2001","unstructured":"Jagannathan, S., T. P. Forsyth, and C. A. Kettner. 2001. Synthesis of boronic acid analogues of alpha-amino acids by introducing side chains as electrophiles. J. Org. Chem.66:6375-6380.","journal-title":"J. Org. Chem."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7293"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"15106","DOI":"10.1016\/S0021-9258(17)42521-X","volume":"259","year":"1984","unstructured":"Kettner, C. A., and A. B. Shenvi. 1984. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids. J. Biol. Chem.259:15106-15114.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10277"},{"key":"e_1_3_2_26_2","first-page":"23","year":"1986","unstructured":"Knight, C. G. 1986. The characterization of enzyme inhibition, p. 23-51. In A. J. Barrett and G. Salvesen (ed.), Proteinase inhibitors. Elsevier, Amsterdam, The Netherlands.","journal-title":"Proteinase inhibitors"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi001907c"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1073\/pnas.1032865100","volume":"100","year":"2003","unstructured":"Komiyama, T., B. VanderLugt, M. Fugere, R. Day, R. J. Kaufman, and R. S. Fuller. 2003. Optimization of protease-inhibitor interactions by randomizing adventitious contacts. Proc. Natl. Acad. Sci. USA100:8205-8210.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.33.23229"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210321200"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/33.5.1005","volume":"33","year":"1994","unstructured":"Mahmoud, B. M., H. M. Ali, M. M. Homeida, and J. L. Bennett. 1994. Significant reduction in chloroquine bioavailability following coadministration with the Sudanese beverages Aradaib, Karkadi and Lemon. J. Antimicrob. Chemother.33:1005-1009.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32036-7"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.55.1.647"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb711"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbrc.2004.07.012","volume":"321","year":"2004","unstructured":"Peinado, J. R., M. M. Kacprzak, S. H. Leppla, and I. Lindberg. 2004. Cross-inhibition between furin and lethal factor inhibitors. Biochem. Biophys. Res. Commun.321:601-605.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/385833a0"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"36219","DOI":"10.1074\/jbc.M400338200","volume":"279","year":"2004","unstructured":"Podsiadlo, P., T. Komiyama, R. S. Fuller, and O. Blum. 2004. Furin inhibition by compounds of copper and zinc. J. Biol. Chem.279:36219-36227.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr010168i"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.602-605.2004"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)47273-6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427010-00003"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007691-198907000-00001","volume":"11","year":"1989","unstructured":"Titus, E. O. 1989. Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine. Ther. Drug Monit.11:369-379.","journal-title":"Ther. Drug Monit."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb708"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.9.3875-3882.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.9.3875-3882.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:56:33Z","timestamp":1645469793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.9.3875-3882.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1128\/AAC.49.9.3875-3882.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.9.3875-3882.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"2005-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}